---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-019997"
form_type: "8-K"
ticker: "CLCS"
cik: "0001569340"
company_name: "Cell Source, Inc."
filed_at: "2022-07-21T23:59:59+00:00"
generated_at: "2026-06-24T09:58:49.611642+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Two directors resign from Cell Source board, no disagreements cited

## Summary
- Ben Friedman resigned as director on July 18, 2022.
- David Zolty resigned as director on the same date.
- Neither resignation was due to any disagreement with the company.
- No replacements have been announced.

## SEC filing metadata
- accession: 0001493152-22-019997
- form_type: 8-K
- ticker: CLCS
- cik: 0001569340
- company_name: Cell Source, Inc.
- filed_at: 2022-07-21T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1569340/000149315222019997/0001493152-22-019997-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1569340/000149315222019997/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-019997
- JSON: https://secwatch.observer/filing/0001493152-22-019997.json
- Plain text: https://secwatch.observer/filing/0001493152-22-019997.txt

## Key facts
- Executive change
  David Zolty resigned as director at Cell Source, Inc..
  - Action: resigned
  - Role: director
  source text: On July 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of Cell Source, Inc. (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1569340/000149315222019997/0001493152-22-019997-index.htm
- Executive change
  Ben Friedman resigned as director at Cell Source, Inc..
  - Action: resigned
  - Role: director
  source text: On July 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of Cell Source, Inc. (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1569340/000149315222019997/0001493152-22-019997-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.